Leaders from OpenAI, Anthropic, Google DeepMind, and Microsoft AI have signed an open letter calling for mandatory legislative checks on clients and orders from synthetic DNA and RNA suppliers, according to WIRED.
The publication reports that the appeal was supported by Sam Altman (OpenAI), Dario Amodei (Anthropic), Demis Hassabis (Google DeepMind), and Mustafa Suleyman (Microsoft AI). The agreement also includes scientists, national security experts, and representatives from the gene synthesis industry.
The initiative’s authors proposed that suppliers be required to screen orders for synthetic nucleic acids and maintain records of such transactions. The letter specifically emphasizes the need for client identity verification and equipment control.
The appeal notes that the rapid development of AI reduces “knowledge barriers,” potentially allowing malicious actors to use neural networks to design dangerous pathogens and toxins, bypassing previous restrictions. Order screening is described as one of the most effective and “least burdensome” ways to mitigate biological threats.
WIRED highlighted that some companies, such as Twist Bioscience, voluntarily conduct such checks as part of an industry consortium, yet no unified federal regulations exist in the US.
Earlier, a bipartisan bill was introduced in the Senate to require all gene synthesis providers in the country to screen their counterparts for ties to terrorist organizations or attempts to recreate dangerous viruses.
In June 2025, one of the largest medical charities, Wellcome Trust, allocated £10 million to launch the world’s first project to create parts or even entire DNA from scratch.